National Research Corporation (NRC)
USD 10.78
(0.75%)
USD 10.78
(0.75%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 148.58 Million USD | -1.97% |
| 2022 | 151.56 Million USD | 2.44% |
| 2021 | 147.95 Million USD | 11.01% |
| 2020 | 133.27 Million USD | 4.14% |
| 2019 | 127.98 Million USD | 6.93% |
| 2018 | 119.68 Million USD | 1.81% |
| 2017 | 117.55 Million USD | 7.47% |
| 2016 | 109.38 Million USD | 6.88% |
| 2015 | 102.34 Million USD | 3.55% |
| 2014 | 98.83 Million USD | 6.75% |
| 2013 | 92.59 Million USD | 7.14% |
| 2012 | 86.42 Million USD | 14.06% |
| 2011 | 75.76 Million USD | 19.51% |
| 2010 | 63.39 Million USD | 9.89% |
| 2009 | 57.69 Million USD | 13.09% |
| 2008 | 51.01 Million USD | 4.27% |
| 2007 | 48.92 Million USD | 11.77% |
| 2006 | 43.77 Million USD | 34.95% |
| 2005 | 32.43 Million USD | 9.27% |
| 2004 | 29.68 Million USD | 10.26% |
| 2003 | 26.92 Million USD | 20.26% |
| 2002 | 22.38 Million USD | 26.67% |
| 2001 | 17.67 Million USD | -3.51% |
| 2000 | 18.31 Million USD | 0.64% |
| 1999 | 18.2 Million USD | 2.82% |
| 1998 | 17.7 Million USD | 8.59% |
| 1997 | 16.3 Million USD | 29.37% |
| 1996 | 12.6 Million USD | 41.3% |
| 1995 | 8.91 Million USD | 32.01% |
| 1994 | 6.75 Million USD | 140.31% |
| 1993 | 2.81 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 35.31 Million USD | -7.07% |
| 2024 Q2 | 35.02 Million USD | -0.83% |
| 2024 Q3 | 35.81 Million USD | 2.28% |
| 2023 Q3 | 37.94 Million USD | 4.93% |
| 2023 Q4 | 38 Million USD | 0.15% |
| 2023 FY | 148.58 Million USD | -1.97% |
| 2023 Q1 | 36.47 Million USD | -4.38% |
| 2023 Q2 | 36.16 Million USD | -0.86% |
| 2022 Q4 | 38.14 Million USD | 1.2% |
| 2022 Q2 | 37.29 Million USD | -2.99% |
| 2022 FY | 151.56 Million USD | 2.44% |
| 2022 Q1 | 38.44 Million USD | 0.37% |
| 2022 Q3 | 37.69 Million USD | 1.07% |
| 2021 Q1 | 35.46 Million USD | 1.98% |
| 2021 FY | 147.95 Million USD | 11.01% |
| 2021 Q2 | 36.42 Million USD | 2.71% |
| 2021 Q4 | 38.29 Million USD | 1.41% |
| 2021 Q3 | 37.76 Million USD | 3.68% |
| 2020 Q1 | 33.86 Million USD | 3.79% |
| 2020 Q2 | 31.16 Million USD | -7.96% |
| 2020 Q3 | 33.47 Million USD | 7.42% |
| 2020 Q4 | 34.77 Million USD | 3.87% |
| 2020 FY | 133.27 Million USD | 4.14% |
| 2019 Q1 | 31.48 Million USD | 2.74% |
| 2019 Q2 | 31.41 Million USD | -0.21% |
| 2019 Q3 | 32.46 Million USD | 3.35% |
| 2019 Q4 | 32.62 Million USD | 0.49% |
| 2019 FY | 127.98 Million USD | 6.93% |
| 2018 Q4 | 30.63 Million USD | 2.09% |
| 2018 Q3 | 30.01 Million USD | 7.12% |
| 2018 FY | 119.68 Million USD | 1.81% |
| 2018 Q2 | 28.01 Million USD | -9.67% |
| 2018 Q1 | 31.01 Million USD | 3.75% |
| 2017 Q1 | 30.27 Million USD | 6.73% |
| 2017 FY | 117.55 Million USD | 7.47% |
| 2017 Q4 | 29.89 Million USD | 3.27% |
| 2017 Q3 | 28.95 Million USD | 1.81% |
| 2017 Q2 | 28.43 Million USD | -6.08% |
| 2016 Q3 | 27.03 Million USD | 3.52% |
| 2016 FY | 109.38 Million USD | 6.88% |
| 2016 Q2 | 26.11 Million USD | -6.3% |
| 2016 Q1 | 27.87 Million USD | 5.71% |
| 2016 Q4 | 28.36 Million USD | 4.94% |
| 2015 Q4 | 26.36 Million USD | 4.44% |
| 2015 Q2 | 24.46 Million USD | -6.87% |
| 2015 Q1 | 26.27 Million USD | 4.56% |
| 2015 FY | 102.34 Million USD | 3.55% |
| 2015 Q3 | 25.24 Million USD | 3.19% |
| 2014 Q4 | 25.12 Million USD | 6.09% |
| 2014 FY | 98.83 Million USD | 6.75% |
| 2014 Q3 | 23.68 Million USD | -1.33% |
| 2014 Q2 | 24 Million USD | -7.79% |
| 2014 Q1 | 26.03 Million USD | 13.55% |
| 2013 Q2 | 22.35 Million USD | -10.25% |
| 2013 Q1 | 24.9 Million USD | 13.23% |
| 2013 FY | 92.59 Million USD | 7.14% |
| 2013 Q4 | 22.92 Million USD | 2.3% |
| 2013 Q3 | 22.4 Million USD | 0.24% |
| 2012 Q2 | 20.63 Million USD | -7.92% |
| 2012 Q3 | 21.38 Million USD | 3.65% |
| 2012 FY | 86.42 Million USD | 14.06% |
| 2012 Q4 | 21.99 Million USD | 2.85% |
| 2012 Q1 | 22.4 Million USD | 17.24% |
| 2011 Q1 | 19.79 Million USD | 24.6% |
| 2011 Q2 | 18.31 Million USD | -7.45% |
| 2011 Q3 | 18.54 Million USD | 1.27% |
| 2011 Q4 | 19.11 Million USD | 3.04% |
| 2011 FY | 75.76 Million USD | 19.51% |
| 2010 FY | 63.39 Million USD | 9.89% |
| 2010 Q1 | 17.37 Million USD | 25.49% |
| 2010 Q2 | 14.13 Million USD | -18.6% |
| 2010 Q3 | 16 Million USD | 13.2% |
| 2010 Q4 | 15.88 Million USD | -0.77% |
| 2009 Q2 | 13.59 Million USD | -18.79% |
| 2009 FY | 57.69 Million USD | 13.09% |
| 2009 Q4 | 13.84 Million USD | 2.4% |
| 2009 Q3 | 13.51 Million USD | -0.57% |
| 2009 Q1 | 16.73 Million USD | 37.33% |
| 2008 Q1 | 13.45 Million USD | 24.34% |
| 2008 FY | 51.01 Million USD | 4.27% |
| 2008 Q2 | 11.9 Million USD | -11.54% |
| 2008 Q4 | 12.18 Million USD | -9.49% |
| 2008 Q3 | 13.46 Million USD | 13.17% |
| 2007 Q1 | 12.2 Million USD | 18.29% |
| 2007 FY | 48.92 Million USD | 11.77% |
| 2007 Q4 | 10.82 Million USD | -22.44% |
| 2007 Q3 | 13.95 Million USD | 16.8% |
| 2007 Q2 | 11.94 Million USD | -2.13% |
| 2006 Q2 | 10.66 Million USD | 12.53% |
| 2006 Q1 | 9.47 Million USD | 10.74% |
| 2006 Q3 | 13.31 Million USD | 24.85% |
| 2006 Q4 | 10.31 Million USD | -22.5% |
| 2006 FY | 43.77 Million USD | 34.95% |
| 2005 Q1 | 6.59 Million USD | 2.59% |
| 2005 Q2 | 7.14 Million USD | 8.38% |
| 2005 Q4 | 8.55 Million USD | -15.54% |
| 2005 FY | 32.43 Million USD | 9.27% |
| 2005 Q3 | 10.13 Million USD | 41.72% |
| 2004 Q4 | 6.43 Million USD | -31.01% |
| 2004 Q3 | 9.32 Million USD | 46.29% |
| 2004 Q2 | 6.37 Million USD | -15.73% |
| 2004 Q1 | 7.56 Million USD | 12.15% |
| 2004 FY | 29.68 Million USD | 10.26% |
| 2003 Q1 | 6.05 Million USD | -2.64% |
| 2003 FY | 26.92 Million USD | 20.26% |
| 2003 Q4 | 6.74 Million USD | -15.66% |
| 2003 Q3 | 7.99 Million USD | 30.43% |
| 2003 Q2 | 6.12 Million USD | 1.17% |
| 2002 Q4 | 6.22 Million USD | -14.96% |
| 2002 Q3 | 7.31 Million USD | 52.45% |
| 2002 Q1 | 4.04 Million USD | -1.52% |
| 2002 FY | 22.38 Million USD | 26.67% |
| 2002 Q2 | 4.79 Million USD | 18.55% |
| 2001 Q3 | 6.1 Million USD | 81.28% |
| 2001 FY | 17.67 Million USD | -3.51% |
| 2001 Q4 | 4.11 Million USD | -32.66% |
| 2001 Q1 | 4.09 Million USD | -2.74% |
| 2001 Q2 | 3.36 Million USD | -17.67% |
| 2000 Q3 | 5.01 Million USD | 8.17% |
| 2000 FY | 18.31 Million USD | 0.64% |
| 2000 Q4 | 4.2 Million USD | -16.17% |
| 2000 Q2 | 4.63 Million USD | 4.12% |
| 2000 Q1 | 4.45 Million USD | -3.16% |
| 1999 Q2 | 4.3 Million USD | 16.22% |
| 1999 Q1 | 3.7 Million USD | -19.57% |
| 1999 Q4 | 4.6 Million USD | -17.86% |
| 1999 Q3 | 5.6 Million USD | 30.23% |
| 1999 FY | 18.2 Million USD | 2.82% |
| 1998 Q4 | 4.6 Million USD | -17.86% |
| 1998 Q3 | 5.6 Million USD | 40.0% |
| 1998 Q2 | 4 Million USD | 17.65% |
| 1998 Q1 | 3.4 Million USD | -26.09% |
| 1998 FY | 17.7 Million USD | 8.59% |
| 1997 FY | 16.3 Million USD | 29.37% |
| 1997 Q1 | 3.4 Million USD | 0.0% |
| 1997 Q2 | 3.5 Million USD | 2.94% |
| 1997 Q4 | 4.6 Million USD | -2.13% |
| 1997 Q3 | 4.7 Million USD | 34.29% |
| 1996 FY | 12.6 Million USD | 41.3% |
| 1995 FY | 8.91 Million USD | 32.01% |
| 1994 FY | 6.75 Million USD | 140.31% |
| 1993 FY | 2.81 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Augmedix, Inc. | 44.85 Million USD | -231.245% |
| OneMedNet Corporation | 1.02 Million USD | -14443.127% |
| Minerva Surgical, Inc. | 50.29 Million USD | -195.423% |
| CareCloud, Inc. | 117.05 Million USD | -26.927% |
| CareCloud, Inc. | 117.05 Million USD | -26.927% |
| HealthEquity, Inc. | 999.58 Million USD | 85.136% |
| iCoreConnect Inc. | 8.15 Million USD | -1722.713% |
| Progyny, Inc. | 1.08 Billion USD | 86.351% |
| Renalytix Plc | 2.28 Million USD | -6391.044% |
| Schrödinger, Inc. | 216.66 Million USD | 31.424% |
| Simulations Plus, Inc. | 70.01 Million USD | -112.218% |
| SOPHiA GENETICS SA | 62.37 Million USD | -138.22% |
| Omnicell, Inc. | 1.14 Billion USD | 87.047% |
| BrightSpring Health Services, Inc. Common Stock | 8.82 Billion USD | 98.317% |
| Streamline Health Solutions, Inc. | 22.59 Million USD | -557.55% |
| Inovalon Holdings, Inc. | 667.52 Million USD | 77.742% |
| Ontrak, Inc. | 12.74 Million USD | -1065.973% |
| Nutex Health, Inc. | 247.64 Million USD | 40.003% |
| GE HealthCare Technologies Inc. | 19.55 Billion USD | 99.24% |
| Sharecare, Inc. | 445.25 Million USD | 66.63% |
| Aclarion, Inc. | 75.4 Thousand USD | -196945.25% |
| CareMax, Inc. | 751.1 Million USD | 80.218% |
| Bullfrog AI Holdings, Inc. Common Stock | 65 Thousand USD | -228484.615% |
| Forian Inc. | 20.48 Million USD | -625.441% |
| Bullfrog AI Holdings, Inc. Warrants | 65 Thousand USD | -228484.615% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 202.56 Million USD | 26.651% |
| SCWorx Corp. | 3.8 Million USD | -3804.921% |
| Definitive Healthcare Corp. | 251.41 Million USD | 40.902% |
| 10x Genomics, Inc. | 618.72 Million USD | 75.986% |
| Zhongchao Inc. | 19.43 Million USD | -664.539% |
| Accolade, Inc. | 414.29 Million USD | 64.136% |
| MSP Recovery, Inc. | 7.7 Million USD | -1828.358% |
| R1 RCM Inc. | 2.25 Billion USD | 93.409% |
| Spok Holdings, Inc. | 139.02 Million USD | -6.873% |
| Privia Health Group, Inc. | 1.65 Billion USD | 91.037% |
| EUDA Health Holdings Limited | 3.7 Million USD | -3908.679% |
| TruBridge, Inc. | 339.43 Million USD | 56.227% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 8.82 Billion USD | 98.317% |
| Sharecare, Inc. | 445.25 Million USD | 66.63% |
| Health Catalyst, Inc. | 295.93 Million USD | 49.794% |
| GoodRx Holdings, Inc. | 750.26 Million USD | 80.196% |
| Premier, Inc. | 1.34 Billion USD | 88.964% |
| HealthStream, Inc. | 279.06 Million USD | 46.758% |
| Certara, Inc. | 354.33 Million USD | 58.068% |
| GeneDx Holdings Corp. | 202.56 Million USD | 26.651% |
| Ontrak, Inc. | 12.74 Million USD | -1065.973% |
| SHL Telemedicine Ltd. | 57.07 Million USD | -160.324% |
| CareCloud, Inc. | 117.05 Million USD | -26.927% |
| EUDA Health Holdings Limited | 3.7 Million USD | -3908.679% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 731.49 Thousand USD | -20211.883% |
| CareMax, Inc. | 751.1 Million USD | 80.218% |
| Healthcare Triangle, Inc. | 33.2 Million USD | -347.49% |
| Aclarion, Inc. | 75.4 Thousand USD | -196945.25% |
| OptimizeRx Corporation | 71.52 Million USD | -107.742% |